Abstract:Roberto W Dal Negro, 1 Paola Turco, 1 Massimiliano Povero 2 1 National Centre for Respiratory Pharmacoeconomics and Pharmacoepidemiology - CESFAR, Verona, Italy; 2 AdRes Health Economics and Outcomes Research, Turin, Italy Correspondence: Massimiliano Povero, Email Background: Chronic Obstructive Pulmonary Disease (COPD) is a respiratory condition characterized by heterogeneous abnormalities of the airways and lung parenchyma that cause different clinical presentations. The assessment of the prevailing pathogenetic components underlying COPD is not usually pursued in daily practice, also due to technological limitations and cost. Aim: To assess non-invasively the lung emphysema component of COPD by the simultaneous measurement of DL NO and DL CO via a single-breath (sDL NO and sDL CO ). Methods: COPD patients aged ≥ 40 years of both genders were recruited consecutively and labelled by computed tomography as "with significant" emphysema (> 10% of CT lung volume) or "with negligible" emphysema otherwise. Current lung function tests such as sDL NO , sDL CO and Vc (the lung capillary blood volume) were measured. All possible subsets of independent spirometric and diffusive parameters were tested as predictors of emphysema, and their predicted power compared to each parameter alone by ROC analysis and area under the curve (AUC). Results: Thirty-one patients with "significant emphysema" were compared to thirty-one with "negligible emphysema". FEV 1 and FEV1/FVC seemed to be the best spirometric predictors (AUC 0.80 and 0.81, respectively), while sDL CO and Vc had the highest predicted power among diffusive parameters (AUC 0.92 and 0.94, respectively). sDL CO and Vc values were the parameters most correlated to the extent of CT emphysema. Six subsets of independent predictors were identified and included at least one spirometric and one diffusive parameter. According to goodness-to-fit scores (AIC, BIC, log-likelihood and pseudo R 2 ), RV coupled with sDL CO or Vc proved the best predictors of emphysema. Conclusion: When investigating the parenchymal destructive component due to emphysema occurring in COPD, sDL NO , sDL CO and Vc do enhance the predictive power of current spirometric measures substantially. sDL NO , sDL CO and Vc contribute to phenotype of the main pathogenetic components of COPD easily and with high sensitivity. Organizational problems, radiation exposure, time and costs could be reduced, while personalized and precision medicine could be noticeably implemented. Keywords: COPD, parenchymal destruction, emphysema, lung capillary blood volume, simultaneous single-breath NO and CO diffusing capacity, precision medicine Chronic obstructive pulmonary disease (COPD) is a pathological condition of the lung that is characterized by persistent respiratory symptoms (cough, expectoration, dyspnea) due to heterogeneous disorders affecting the airways and/or the lung parenchyma to a variable extent. 1 Though characterized by significant progression and by huge epidemiological and socio-economic impact worldwide, 2–4 Nevertheless, COPD is described as a preventable and treatable condition. 1 It is known since long ago that the pathogenetic components underlying COPD can variably involve all structures of lung units, such as the conductive airways, the small airways and/or the alveoli, the capillary vasculature included. 5–7 Such a pathogenetic heterogeneity entails different clinical presentations of COPD: the clinical phenotypes of COPD. 8–19 Different COPD phenotypes can be obviously characterized by variable responses to therapeutic regimens due to the variable extent of reversible and irreversible components of structural disorders occurring in the lung, and consequently different short- and long-term outcomes can be expected. Unfortunately, respiratory conditions characterized by the predominant airway involvement and those where the parenchymal destruction is prevailing are currently included in the same comprehensive term "COPD", both in clinical practice and in the vast majority of RCTs. In the aim of defining the right pattern of lung function occurring in COPD and the existence of some destructive parenchymal components, measurements of diffusing capacity for carbon monoxide (DL CO ) are currently recommended together to the assessment of static and dynamic volumes, forced flows, airway resistances, and residual volume. However, due to the slow binding of CO with intracapillary hemoglobin (Hb), usual measurements of DL CO are consi -Abstract Truncated-

Influence of the type of emphysema in the relationship between COPD and lung cancer

Effect of Emphysema on Lung Cancer Risk in Smokers: A Computed Tomography–Based Assessment

A retrospective study of clinical features of patients with emphysema complicated with lung cancer

Is There a Link between Chronic Obstructive Pulmonary Disease and Lung Adenocarcinoma? A Clinico-Pathological and Molecular Study

Computed Tomography Characterization of Emphysema in Combined Pulmonary Fibrosis and Emphysema (CPFE) and Its Correlation with Lung Cancer with Comparison to Chronic Obstructive Pulmanory Disease (COPD)

Analysis of clinical characteristics and prognosis of lung cancer patients with CPFE or COPD: a retrospective study

Meta-analysis: clinical features and treatments of lung cancer in combined pulmonary fibrosis and emphysema

Impact of combined pulmonary fibrosis and emphysema on lung cancer risk and mortality in rheumatoid arthritis: A multicenter retrospective cohort study

Clinical characteristics and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema: a systematic review and meta-analysis of 13 studies.

Immune Cell Subtypes and Cytokines in Lung Tumor Microenvironment: Influence of COPD

Contribution of Emphysema and Small Airways in COPD

Impact of COPD on prognosis of lung cancer: from a perspective on disease heterogeneity

Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema Revisited with the 2015 World Health Organization Classification of Lung Tumors.

Contributions of Emphysema and Functional Small Airway Disease on Intrapulmonary Vascular Volume in COPD

Impact of Emphysema Heterogeneity on Pulmonary Function.

Opposing Effects of Emphysema, Hay Fever, and Select Genetic Variants on Lung Cancer Risk.

The Association Between Small Airway Obstruction and Emphysema Phenotypes in COPD

Influence of radiological emphysema on lung function test in idiopathic pulmonary fibrosis

Single-Breath Simultaneous Measurement of DLNO and DLCO as Predictor of the Emphysema Component in COPD – A Retrospective Observational Study

Analysis of individuals presenting phenotypes of extreme high and low risk of developing tobbacco-induced lung cancer.

The relationship between airflow obstruction, emphysema extent, and small airways function in COPD